Hosted on MSN6d
MedMira Receives Authorization for Syphilis Test Clinical Trials
Medmira ( ($TSE:MIR) ) has provided an update. MedMira Inc. has received investigational testing authorization from Health Canada to commence ...
MedMira, Inc.: MedMira Receives Health Canada Approval for Its Reveal G4 Rapid HIV-1/2 Test for Point-of-Care Use
HALIFAX, NS / ACCESSWIRE / January 14, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today the approval from Health Canada for its Reveal®Rapid G4 HIV-1/2 Test (Reveal® ...